GLOBETTI V. SANDOZ PHARMACEUTICALS CORP. 111 F.Supp.2d 1174 (N.D. Ala. 2000) CASE BRIEF

GLOBETTI V. SANDOZ PHARMACEUTICALS CORP.
111 F.Supp.2d 1174 (N.D. Ala. 2000)
NATURE OF THE CASE: Globetti (P) alleged that a drug manufactured by Sandoz (D) caused P's wife to have an acute myocardial infarction following the birth of her sixth child. D moved for summary judgment on the issue of causation.
FACTS: P was 33 years old and pregnant with her sixth child. Her health was good. She had no known risk factors for coronary disease; she had no family history of heart disease, was not a smoker, was not overweight, was relatively young, and had very low (indeed, 'protective') cholesterol levels. Neither during the pregnancy nor the delivery did she experience any hypertension, and she had no history of high blood pressure. After giving birth, she decided not to breast feed, so, pursuant to a standing order of her obstetrician for non-breast feeding mothers, she was given 2.5 mg of, twice daily for fourteen days, to suppress lactation. P had taken Parlodel before in connection with some or all of her five prior deliveries. P began to experience chest pain and was rushed to the emergency room. She had suffered an acute myocardial infarction of the anterior wall of her left ventricle. P was ordered to avoid Parlodel. P sued D and D moved for summary judgment based on medical causation. P's trial experts expressed the opinion that the Parlodel caused or contributed to the arterial spasm that caused her heart attack.

ISSUE:


RULE OF LAW:


HOLDING AND DECISION:


LEGAL ANALYSIS:





Get free access to the entire content for Mac, PC or Online

for 2-3 days and free samples of all kinds of products.

https://bsmsphd.com




© 2007-2016 Abn Study Partner

No comments:

Post a Comment